Why Aren’t Democrats Talking About Ending Patent-Financed Drug Research?
Americans will spend more than $460B on prescription drugs in 2019. This could easily be reduced to $80B, so why don’t Democrats get with the program? Dean Baker writes.
At the Dawn of Hope, Trepidation in Turkey
In the wake of the Istanbul elections, how will Turkey’s ruling party respond? Neslihan Özgüneş considers the fate of political prisoners.
As battle for Istanbul reaches fever pitch, Turkey’s ruling party regrets its pop culture problem
Pop stars and actors are political assets and Turkey’s ruling AKP party is losing them. Sevgi Yağmur Bulut reports.
Puerto Rico’s Botched Disaster Relief, Unsustainable Debt, and Economic Failure Linked to its Colonial Status
Puerto Rico’s status as a mere colony of the US creates graft, greed and corruption that makes US advisers rich and citizens poor. Mark Weisbrot explains.
The Manchurian Sidranist
Jeff Stevens PACsplains the 2019 Seattle City Council candidate clown car.
The US Labor Market is Deteriorating for Black Men
While the unemployment rate falls across the nation, unemployment for Black men rises. Why? Dean Baker examines.
Art and Activism at the Lebanese-Syrian Border
Anaïs Ortega Druml on finding music and art in the battle zone.
Putting Numbers into Context: A Winnable Battle Our Side Doesn’t Want to Fight
Putting numbers into context is easy and helps people understand what social programs actually cost. So why don’t reporters do it? Dean Baker writes.
Brotherly Nations or Family Feud—The Qatar Crisis Explained
Our correspondent in the Middle East gets down and dirty about Qatar and its neighbors.
Except where otherwise noted, the content on this site is licensed under a Creative Commons Attribution 4.0 International License.